[
    [
        {
            "time": "2023-10-01",
            "original_text": "沃森生物：公司产品生产和批签发的工作均在正常开展",
            "features": {
                "keywords": [
                    "产品生产",
                    "批签发",
                    "正常开展"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：公司产品生产和批签发的工作均在正常开展",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-02",
            "original_text": "沃森生物：公司新冠mRNA疫苗在菲律宾的三期临床试验正在按计划推进中",
            "features": {
                "keywords": [
                    "新冠mRNA疫苗",
                    "菲律宾",
                    "三期临床",
                    "按计划推进"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：公司新冠mRNA疫苗在菲律宾的三期临床试验正在按计划推进中",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-03",
            "original_text": "沃森生物(300142.SZ)：向中国妇女发展基金会捐赠现金1150万元",
            "features": {
                "keywords": [
                    "捐赠",
                    "中国妇女发展基金会",
                    "1150万元"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "社会责任"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物(300142.SZ)：向中国妇女发展基金会捐赠现金1150万元",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-04",
            "original_text": "沃森生物：控股子公司上海泽润获新老股东拟增资3.5亿元",
            "features": {
                "keywords": [
                    "上海泽润",
                    "增资",
                    "3.5亿元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "子公司"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物：控股子公司上海泽润获新老股东拟增资3.5亿元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "沃森生物(300142.SZ)：子公司收到1项境外发明专利证书",
            "features": {
                "keywords": [
                    "子公司",
                    "发明专利",
                    "境外"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "知识产权",
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物(300142.SZ)：子公司收到1项境外发明专利证书",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-06",
            "original_text": "沃森生物(300142.SZ)：控股子公司上海泽润获新老股东拟增资3.5亿元 欲加快推进HPV疫苗临床研究和产业化上市进程",
            "features": {
                "keywords": [
                    "上海泽润",
                    "增资",
                    "HPV疫苗",
                    "临床研究",
                    "产业化"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "HPV疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物(300142.SZ)：控股子公司上海泽润获新老股东拟增资3.5亿元 欲加快推进HPV疫苗临床研究和产业化上市进程",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 10,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-10-07",
            "original_text": "沃森生物(300142.SZ)：上海泽润收到一项马来西亚发明专利证书",
            "features": {
                "keywords": [
                    "上海泽润",
                    "发明专利",
                    "马来西亚"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "知识产权",
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物(300142.SZ)：上海泽润收到一项马来西亚发明专利证书",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-08",
            "original_text": "沃森生物(300142.SZ)拟对上海泽润增资1亿元 推进HPV系列疫苗临床研究和产业化进程",
            "features": {
                "keywords": [
                    "上海泽润",
                    "增资",
                    "HPV系列疫苗",
                    "临床研究",
                    "产业化"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "HPV疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物(300142.SZ)拟对上海泽润增资1亿元 推进HPV系列疫苗临床研究和产业化进程",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-09",
            "original_text": "沃森生物现1笔大宗交易 共成交434.93万元",
            "features": {
                "keywords": [
                    "大宗交易",
                    "434.93万元"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "交易活动"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物现1笔大宗交易 共成交434.93万元",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "沃森生物今日大宗交易成交7.30万股，成交价59.58元溢价0.0%",
            "features": {
                "keywords": [
                    "大宗交易",
                    "7.30万股",
                    "59.58元",
                    "溢价0.0%"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "交易活动"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物今日大宗交易成交7.30万股，成交价59.58元溢价0.0%",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        }
    ]
]